We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

HP Speeds Drug Discovery Research with Inkjet Technology

Read time: Less than a minute

HP high-performance inkjet dispensing technology is now being used to speed the evaluation of how potential drug compounds impact biologic agents like cancer cells at very low concentrations. This new capability can help researchers significantly improve accuracy when evaluating drug safety and effectiveness, testing for drug interactions and developing new drugs.

HP’s methodology also can decrease expensive labware and biological fluid waste associated with complex, conventional testing methods, reducing research costs. The process also can improve productivity by eliminating many time-consuming and tedious steps in the drug discovery process.

HP is working with several leading pharmaceutical companies to incorporate its dispensing technology into their own work flows with very promising results. Pharmaceutical companies invest nearly $16 billion in drug discovery research each year, evaluating novel chemical compounds as potential drugs to prevent or treat diseases such as diabetes or cancer.

By repurposing its most advanced inkjet technology to address the needs of this important market space, HP can quickly bring new value to the biopharmaceutical industry. HP continues to evaluate other important new market spaces, such as in-vitro diagnostics, where its inkjet technology can have a positive impact.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.